Full name
CARDIOCARE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA
uses securityreCAPTCHA
72.19.Z - Other research and experimental development on natural sciences and engineering
46.1 - Wholesale on a fee or contract basis
47.1 - Retail sale in non-specialised stores
68.20.Z - Rental and operating of own or leased real estate
71.20.A - Food quality testing and analysis
71.20.B - Other technical testing and analysis
72.11.Z - Research and experimental development on biotechnology
75.00.Z - Veterinary activities
86.10.Z - Hospital activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,1 | -0,5 | -0,4 | 31,7 |
EBITDA | -0 | 0,2 | 0,4 | 105 |
Short time liabilities | 1,1 | 0,5 | 4,2 | 787,3 |
Equity capital | 0,7 | 1,6 | 1,2 | -23,5 |
Operating profit (EBIT) | -0,1 | -0,5 | -0,2 | 53,4 |
Assets | 5,3 | 4,3 | 7,7 | 77,2 |
Net profit (loss) | -0,1 | -0,5 | -0,4 | 31,7 |
Cash | 2,7 | 1,2 | 0,1 | -87,5 |
Net income from sale | 1,1 | 1,3 | 4,8 | 256,7 |
Liabilities and provisions for liabilities | 4,6 | 2,7 | 6,5 | 135,6 |
Working assets | 4,1 | 3,7 | 7,7 | 105,7 |
Depreciation | 0 | 0,7 | 0,6 | -13,7 |
% | % | % | p.p. | |
Profitability of capital | -14,6 | -34,3 | -30,6 | 3,7 |
Equity capital to total assets | 12,7 | 36,7 | 15,9 | -20,8 |
Gross profit margin | -8,8 | -40,9 | -7,8 | 33,1 |
EBITDA Margin | -4,3 | 13 | 7,5 | -5,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 361 | 129 | 320 | 191 |
Current financial liquidity indicator | 0.8973889946937561 | 1.3606970310211182 | 1.1879268884658813 | -0,2 |
Net dept to EBITDA | 56.005802154541016 | -4.120543479919434 | 11.321537971496582 | 15,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane